Multi-strategy engineering of transaminase enables a one-pot synergistic biocatalytic cascade to a key florfenicol chiral intermediate

Abstract

(1R,2R)-2-Amino-1-(4-(methylsulfonyl)phenyl)propane-1,3-diol [(1R,2R)-3] is a key chiral intermediate for the antibiotic florfenicol. Its asymmetric synthesis remains challenging due to the difficulty in constructing two contiguous stereocenters with high selectivity. Herein, we report a green and sustainable one-pot enzymatic cascade for the efficient synthesis of (1R,2R)-3 from inexpensive and readily available L/D-serine and 4-(methylsulfonyl)benzaldehyde (4-Mb). The cascade starts with the L-amino acid oxidase (AncLAAO)-mediated oxidation of L-serine to produce β-hydroxypyruvate (1). The subsequent pyruvate decarboxylase (SwPDC)-catalyzed decarboxylative condensation led to the asymmetric assembly of 1 and 4-Mb to yield (R)-1,3-dihydroxy-1-(4-(methylsulfonyl)phenyl)propan-2-one [(R)-2], and an engineered transaminase (ATA117) aminates (R)-2 using D-serine as the amine donor to produce the target product (1R,2R)-3. This design inherently enables a one-pot cascade for assess (1R,2R)-3 and prevents the accumulation of inhibitory pyruvate, embodying the principles of atom economy and waste prevention. The rate-limiting transaminase ATA117 was engineered through a multi-strategy approach. The resulting optimal variant, ATA117-Mu9 demonstrated a 39-fold increase in catalytic efficiency (kcat/Km) and a 4.65-fold improvement in (1R,2R)-3 yield (27.9 mM) over the wild-type enzyme while maintaining a high diastereomeric excess (de) of 96-98% throughout the engineering process. For scalable application, a whole-cell biocatalyst BL21(01) co-expressing ancLAAO, SwPDC and ATA117-M9 was constructed. In a 100 mL scale-up reaction, 50 mM of 4-Mb was completely converted to 47.9 mM of (1R,2R)-3 within 3 h, achieving a space-time yield of 3.91 g/L/h, the highest reported for this compound. In summary, this work establishes a simple, efficient, and environmentally benign route that eliminates heavy metals, minimizes waste, and uses benign reaction media, providing a promising green alternative for the industrial synthesis of florfenicol intermediates.

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
20 Dec 2025
Accepted
13 Mar 2026
First published
14 Mar 2026

Green Chem., 2026, Accepted Manuscript

Multi-strategy engineering of transaminase enables a one-pot synergistic biocatalytic cascade to a key florfenicol chiral intermediate

H. Zhao, W. Shen, B. Su, L. Xu and J. Lin, Green Chem., 2026, Accepted Manuscript , DOI: 10.1039/D5GC06908D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements